How to use the speech recognition tool?

ERN-EYE ePAG patient advocates

 

 

What is an ePAG advocate?

Eurordis

In 2016, EURORDIS1 and the European rare disease community established 24 European Patient Advocacy Groups (ePAGs) aligned to the clinical scope of each ERN. Today, there are over 280 ePAG patient advocates to represent the wider patient community in the development of ERNs. 

 

What is the role of an ePAG advocate?

The role of ePAG patient advocates is to represent the voice and interests of their patient community and act as the bridge between this community and the ERN. ePAG patient advocates have an official permanent mandate to represent ePAG member organisations. They liaise with these organisations to ensure true and equitable representation of the patient voice by participating in the Board and sub-clinical committees of their respective ERN. 

 

How to become an ePAG advocate?

Membership of ePAGs is open to all rare disease patient organisations (EURORDIS members and non-members based in the European Union). ePAGs can only benefit from the flow of ideas between a range of member organisations and advocates.

The recruitment of these advocates is ongoing to ensure that patients are fully represented in the governance of each and every ERN. Patient advocates have already been elected to numerous ERNs but additional applications are welcome for all networks. Members and non-members of EURORDIS are encouraged to apply.

 

Contact to become an ePAG

 

1EURORDIS is a non-governmental patient-driven alliance of patient organisations representing 755 rare disease patient organisations in 67 countries.

 

 

ERN-EYE ePAG representatives

ERN-EYE ePAG* roles and responsibilities

DominiqueDominique Sturz

BSVÖ Austrian Association for the Blind & Partially Sighted & Usher Deafblind Forum Austria

Austria

ePAG Chair, representative in the Governance Board

WG3, TWG6, TWG9, TWG10

 

 

Petia StratievaPetia Stratieva

Retina International

 

Bulgaria

ePAG Co-Chair, representative in the Governance Board

WG1, TWG5, TWG6, TWG8

 

 

Russell Wheeler Russell Wheeler

LHON Society UK

 

UK

ePAG 

WG2, TWG7 

 

Michael LaengsfeldMichael Laengsfeld

Pro Retina Germany

 

Germany

WG1, TWG7

 

 

Rosa Sanchez

Aniridia Europe

 

Spain

WG4, TWG7

 

 

Sébastien Montahuc

Association Gêniris

 

France

WG4, TWG7

 

 

Christina Fasser 2Christina Fasser

 

Switzerland

SupP*

WG1, TWG5, TWG7

 

 

*European Patient Advocacy Group

**Supporting Partner

List of the working groups

WG1: Retinal Rare Eye Diseases

WG2: Neuro-Ophthalmology Rare Diseases
WG3: Pediatric Ophthalmology Rare Diseases
WG4: Anterior Segment Rare Eye Diseases
TWG5: Low Vision, Daily Life and Patients Groups
TWG6: Genetic Diagnostics
TWG7: Registries & Epidemiology
TWG8: Research
education TWG9: National Integration
TWG10: CPMS & Digital Medecine

ERN-EYE invites you to meet ePAG representatives within the network through a short interview

Contact

You can contact the ePAG representatives at contact@ern-eye.eu

Subscribe to our mailing list

* indicates required

This ERN is supported by: